Navigation Links
Signum Biosciences Awarded Phase II SBIR Grant by the NIH for the Treatment of Rosacea
Date:9/11/2009

MONMOUTH JUNCTION, N.J., Sept. 11 /PRNewswire/ -- Signum Biosciences, Inc has been awarded a $1.6 million Small Business Innovation Research (SBIR) Phase II grant by the National Institute of Allergy and Infection Diseases (NIAID) to continue the development of its topical STM (Signal Transduction Modulator) anti-inflammatory technology for the treatment of inflammatory skin disease.

In 2008, NIH/NIAID awarded Signum a SBIR Phase I grant to establish this novel class of anti-inflammatories. SBIR Phase II grants enable SBIR Phase I grantees to further develop their technology and prepare it for commercialization. Signum will use the Phase II grant to fund preclinical development of Signum's lead drug candidates for rosacea. Rosacea is a common, chronic cutaneous condition afflicting millions of individuals. FDA approved treatments have yielded mixed results, often leaving patients with significant levels of facial redness. Successful pharmaceutical development of STM anti-inflammatories will provide an important additional, and potentially better, therapeutic option for people suffering from rosacea redness.

The objective of the Phase II grant is to be granted an IND and commence Phase I clinical trials. "We are proud to have been awarded this grant and to have the reviewers at the NIH validate our technology. Building on our Phase I achievements, Signum is dedicated to developing its STM anti-inflammatory platform as novel therapeutics for rosacea as well as several other dermal skin disorders", stated Maxwell Stock, President and Chief Operating Officer.

Signum Biosciences is a private biotechnology company dedicated to developing small-molecule therapeutics derived from its Signal Transduction Modulation platform. Signum is a pioneer of this new technology which modulates targets rather than just switching-them on or off. Through research on protein networks that control biological sys
'/>"/>

SOURCE Signum Biosciences, Inc
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related medicine technology :

1. Regado Biosciences Releases Positive Phase 2a Data for the Reversible Anticoagulant System REG1 at the European Society of Cardiology Congress In Barcelona, Spain
2. Sangamo BioSciences Announces Achievement of Key Milestone in Cell Engineering Agreement With Genentech
3. Neurocrine Biosciences Presents Elagolix Data
4. SAFC Biosciences(R) and Vivalis Collaborate to Optimize Cell Culture Media for Vaccines Production
5. ImQuest BioSciences Receives Phase I SBIR Grant to Develop a Novel Hepatitis C Virus Therapeutic Agent
6. YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY
7. Sangamo BioSciences Announces Presentations at Two Upcoming Investor Conferences
8. Hana Biosciences Announces New Positive Interim Efficacy Results in Pivotal rALLy Clinical Trial of Marqibo in Acute Lymphoblastic Leukemia
9. Hana Biosciences Announces Successful Planned Independent Safety Analysis Supports Ability to Complete Pivotal rALLy Clinical Trial of Marqibo, Its Lead Novel Anti-Cancer Compound
10. Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
11. YM BioSciences Announces Milestone Payment For Approval Of Nimotuzumab In The Philippines And Indonesia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...NORTHHOLLYWOOD,Calif.,Nov.24/PRNewswire-FirstCall/...adingnationalhospitalistphysiciangrouppracticecomp...Chospitalist,wasnamedby ACPHospitalist asoneofthe2...theNovember2009issueofthemagazine. ,, Dr.Vaidya...urrentlyservesasdirectorofhospitalmedicineatSt.Mar...
(Date:11/24/2009)...WAYNE,N.J.,Nov.24/PRNewswire/--MAQUETCardiovascula...announcedtodaythatithassignedaguaranteedtwo-yearco...chasingorganizations,tobethesolesourceproviderofsu...Underthetermsoftheagreement,whichrunsthroughOctobe...viderofbeatingheartdevicesanddisposablesuppliestot...
(Date:11/24/2009)...MOUNTAINVIEW,Calif.,Nov.24/PRNewswire/--SatelliteH...ofkidneydialysisservicesandamajorsponsorofnephrolo...asesurvivorandchefEliasNasrallahinhisefforttosuppo... EliasNasrallahbuiltasuccessfulcareerasachefforthe...fiveyearsago,whenhewasdiagnosedwithEndStageRenalDi...
Breaking Medicine Technology:IPC The Hospitalist Company's Philip Vaidyan, M.D. Named a Top Hospitalist of 2009 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 2MAQUET Cardiovascular Receives Guaranteed Two-Year Sole Source Contract From Novation for Beating Heart Surgical Devices 3Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2Bedazzled Bras Benefit Breastcancer org 59599 1Bedazzled Bras Benefit Breastcancer org 59599 2Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 14496 1Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 14496 2Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 14496 3Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 14496 4Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 14496 5Nutrition 21 Announces Financial Results for Q4 of Fiscal 2009 and Full Year Fiscal 2009 14496 6Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status 5522 1
...RGANTOWN, W.Va., Sept. 5 A team of,researchers at...grants from,India and Pakistan take on the habits ...f prostate cancer among male immigrants and breast...te cancer develop due to many reasons, but,environ...these cancers,",said Jame Abraham, M.D., medical d...
...X-351 awarded orphan designation for the treatment...eukemia, PRINCETON, N.J., Sept. 4 Celator Pharma...g Administration (FDA) has granted orphan,drug des...some Injection,for the treatment of Acute Myeloid ...o conduct two randomized Phase 2,studies with CPX-...
Other Medicine Technology:Immigrants From India, Pakistan Face U.S. Prostate, Breast Cancer Risks 2Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2
(Date:11/24/2009)...PlusofMichiganhaslaunchedfournew HealthPlusSignatu...s18to64andtheirfamilieswhoarelookingtopurchaseaffo...lusSignature plansareavailableonlineat www.HealthP...althPlusservicearea.Moreinformation,includinghelpw...o1-877-562-0907. ,, "Wearepleasedtoofferanarray...
(Date:11/24/2009)...of inflammatory bowel disease is largely unknown, ...9 Advances in Inflammatory Bowel Diseases, the Cro...al & Research Conference, December 3-6 in Holl...tion for Crohn’s disease. , ... The molecular cause of inflammatory bowel disease...
(Date:11/24/2009)...eholidayseasonoftenbringsfamiliesandfriendstogethe...segrievingthedeathofalovedone.Followingadeath,ever...asoncanbringadditionalchallengestothosewhoaregriev...ngChildren,AdolescentsandTheirFamilies,isavailable...fprintandonlineresourcesavailabletohelpchildrengri...
(Date:11/24/2009)...tCall/--HealthSouthCorporation(NYSE: HLS )todayann...nch2009CreditConferenceinNewYorkonDec.2-3,2009. ,...ywillbespeakingonThursday,Dec.3,2009,at3:40p.m.ET....at http://investor.healthsouth.com byclickingonana...hSouthisthenation,slargestproviderofinpatientrehab...
(Date:11/24/2009)...between high- and low-volume centers, study found ... Do hospitals that conduct the most angioplasties ... Maybe not. , Prior research had suggested that...opening procedures, but a new study involving over...als performing more or less equally. , The stud...
Breaking Medicine News(10 mins):Health News:HealthPlus Offers New Insurance Plans for Consumers Seeking Health Coverage on Their Own 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:Highmark Caring Place Resources Help Children and Families Who Are Grieving During the Holidays 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 2Health News:Angioplasty Outcomes May Vary Little Between Hospitals 3
...e, inefficiencies need to be cut out of system in ...hDay News) -- Unless health-care reform becomes a ...nsurance premiums that will double by 2016, a new ...he report, which was released Wednesday by the Pub...
...igest: , , Summary of study being published onl...ncology ,showing no survival difference between pr...cer whose ovaries were left intact during cancer s...gynecologic cancer expert and Director, Division o...
...IS, Jan. 28 Leaders in Indiana are encouraging,Co... health information,technology (IT) program as a m...een $2-5 billion in health IT infrastructure as pa...tructure funding,recommended through this economic...
...Deal Adds Nearly Four Million Unique Visitors per ...and SAN MATEO, Calif., Jan. 28 HealthCentral ( ww...nline condition-specific consumer health and welln...s to HealthCentral,s audience. The acquisition com...
... Kan., Jan. 28 Swiss Re,s Employer Stop Loss ins...ng number of companies interested in self-funding ... The coverage enables employers to cap their liabi... of Columbia through Westport Insurance Corp., the...
...nt data shows little difference from placebo , ... used to treat pain, acupuncture offers only limit...o say Danish researchers who examined data from 13...a wide range of painful conditions such as knee os...
Other Medicine News:Health News:Skyocketing Health-Care Costs Could Double Premiums for Many Americans 2Health News:Skyocketing Health-Care Costs Could Double Premiums for Many Americans 3Health News:Study shows younger women with endometrial cancer can safely keep ovaries, avoid early menopause 2Health News:Congressional Leaders Can Look to Indiana for Innovative Approach to Health IT in Economic Stimulus Package 2Health News:Congressional Leaders Can Look to Indiana for Innovative Approach to Health IT in Economic Stimulus Package 3Health News:Congressional Leaders Can Look to Indiana for Innovative Approach to Health IT in Economic Stimulus Package 4Health News:Congressional Leaders Can Look to Indiana for Innovative Approach to Health IT in Economic Stimulus Package 5Health News:HealthCentral Acquires Wellsphere Creating the Largest Organically Driven Online Health and Wellness Communities 2Health News:HealthCentral Acquires Wellsphere Creating the Largest Organically Driven Online Health and Wellness Communities 3Health News:HealthCentral Acquires Wellsphere Creating the Largest Organically Driven Online Health and Wellness Communities 4Health News:HealthCentral Acquires Wellsphere Creating the Largest Organically Driven Online Health and Wellness Communities 5Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 2Health News:Swiss Re's Employer Stop Loss Product Offers US Companies Cost Savings for Self-Funded Health Insurance Plans 3Health News:Pain-Relieving Powers of Acupuncture Unclear 2
Lap Pad
The Maternity Apron
Back Relief Apron
Wrap-Around Back Relief
Medicine Products: